Tuesday, 5 March 2013

ISCC to Present at 65th American Academy of Neurology Annual Meeting

International Stem Cell Corporation (ISCC) announced today, via a press release, that Dr. Ruslan Semechkin will present the findings of the company's pre-clinical studies on Parkinson's Disease on March 20th, 2013.

Semechkin is ISCC's Vice President of Research and Development and he will present the results at the 65th American Academy of Neurology Annual Meeting at the San Diego Convention Centre. Purpose of the studies was to test the safety and efficacy of neuronal cells, derived from parthenogenetic stem cells, for the treatment of Parkinson's. The studies were carried on rodent and non-human primate models.

Judging from previous press releases, ISCC seems to be quite optimistic regarding their stem cell-based therapies. Hopefully the findings are positive, paving the way for future, human clinical trials.

The official press release is available here

Recent, Related Posts

No comments:

Post a Comment

Please note that we dont offer any kind of medical advice. Questions requesting specific medical advice (e.g. where can I get this treatment, will this cure XXX condition, etc) will be published but most probably ignored by the administrators. :)

Note to spammers: You shall not pass. If you really want a link from us then consider making a stem cell related guest post !